Current role
David Mauro, M.D., Ph.D.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About David Mauro, M.D., Ph.D.
Recursion Pharmaceuticals, Inc. reported in an 8-K filed May 17, 2023 that David Mauro, M.D., Ph.D. was appointed Chief Medical Officer, effective June 1, 2023.
“On May 16, 2023, Recursion Pharmaceuticals, Inc. (the "Company") announced that it has appointed David Mauro, M.D., Ph.D., to the position of Chief Medical Officer, effective June 1, 2023.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-06-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Recursion Pharmaceuticals, Inc.
Other people whose current roles at this company are on record from its filings.
- Christopher C. Gibson CEO, Board Member
- Najat Khan CEO
- Najat Khan, Ph.D. CEO, Board Member
- Christopher Gibson, Ph.D. Chairman
- Robert Hershberg, M.D., Ph.D. Chairman
- Ben Taylor CFO
- Kristen Rushton COO
- Tina Marriott COO
- David Hallett CTO, Board Member
- Blake Borgeson Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.